Patient Beats Thyroid Cancer Without Surgery: Andy’s Story

Andy Barker never planned to see the dermatologist that day. He was only there to keep his wife company at a routine appointment when the doctor offered him a quick skin check. She rolled up his pant leg, looked at a spot he had dismissed as a rogue freckle, and told him it needed to come off immediately.

The spot was melanoma. Surgery removed it, along with part of his lymph node system, and a follow-up PET scan brought the news every cancer patient hopes for. He was clear.

The same scan brought something else: a 1.5 centimeter nodule on his thyroid. Probably nothing, he was told. Lots of people have them. But get a biopsy to be sure.

The fine needle biopsy came back within a day. Papillary thyroid cancer.

“We Need to Talk”

Barker, who turned 50 in 2024 and had rarely dealt with health problems, was still absorbing the melanoma diagnosis when the second one arrived. His endocrinologist called almost immediately after the results posted to the patient portal. The tone, Barker recalls, was urgent and uncomfortable. The recommendation was direct: the cancer was contained in the nodule, they did not want it to break through, and he should find a surgeon and have his thyroid removed.

It is the standard script for papillary thyroid cancer in much of the American medical system, and it is delivered to tens of thousands of patients each year. What most of those patients are not told is that papillary thyroid cancer is typically slow growing, that small nodules may have been present for decades before discovery, and that nonsurgical treatment exists.

Barker’s skepticism started with a set of test results he already had in hand. As part of his post-melanoma workup, his primary doctor had run a baseline panel on his major organs. Everything, including his thyroid, was functioning normally. “You’re telling me, yank this out,” he said. “Something felt wrong.”

His longtime holistic doctor gave him the advice that changed his trajectory: slow down. Papillary cancer is not aggressive, the doctor told him, and no one could say whether the nodule had been there two years or 25. “That helped me think, we’ve got time,” Barker said.

Even the surgeon he consulted, in an appointment Barker describes as dismissive and interrupted by phone calls, conceded the point. Get it out any time in the next year and you’ll be fine, the surgeon told him. Not urgent.

If it was not urgent, Barker reasoned, there was time to research.

The Hangnail Test

Barker frames his objection in plain terms. “If I had a hangnail on my pinky, I’m not going to cut my hand off just because then I’ll never have to worry about a hangnail again.”

His research on alternatives to thyroid removal kept surfacing one option: thermal ablation. In radiofrequency ablation, or RFA, a physician guides a thin electrode into the nodule under ultrasound and uses heat to destroy the targeted tissue. The thyroid stays. The nodule shrinks over months. In experienced hands, the technique is being used not only for benign nodules but, by a small number of highly trained specialists, for selected thyroid cancers.

Searches for terms like “thyroid removal alternatives” led Barker to RFAMD, a global directory of trained thyroid ablation physicians, where he began watching patient interviews and physician videos. The obvious question followed: why had his hospital never mentioned it? The answer, he learned, was simple. No one in the network was trained in the procedure. It was not a tool in their chest.

When he asked his own doctors about ablation, neither had heard of it being used on the thyroid, but both confirmed the technique itself is common in other areas of medicine. That reassured him. This was not fringe. It was an established procedure that had not yet reached his local system.

Twelve Hours to a Path Forward

Reaching an ablation provider proved harder than finding one. Barker spent two months trying to get an appointment with the closest listed physician, stalled by records transfers he could not get his hospital network to complete. Frustrated, he emailed the general contact address on the RFAMD website and explained his situation.

He had a reply within 12 hours. Given his diagnosis, the recommendation was Dr. Emad Kandil, a surgeon in New Orleans and one of the few physicians in the United States treating thyroid cancer with ablation. Kandil’s office was copied on the email. His team reached out within hours that same day.

The distinction matters more than most patients realize. The number of US physicians offering thyroid ablation has grown quickly, but treating a malignant nodule with RFA demands a level of skill and case experience that the vast majority of providers do not have. Roughly 90 percent of thyroid ablation doctors will not treat cancer at all. Complex and malignant cases belong with the handful of specialists who do them routinely.

After reviewing Barker’s records, Kandil told him he was a strong candidate, walked him through the procedure without guarantees, and scheduled him. In the fall of 2024, Barker flew to New Orleans. He was awake and aware throughout the ablation, with the team explaining each step. “It was a great experience,” he said.

The Biopsy Result

At the six-month follow-up, the nodule had shrunk to under one centimeter, below the size threshold that typically triggers investigation in the first place. Kandil recommended one more step for peace of mind: a fresh biopsy.

The result came back with no cancer detected in the nodule.

Barker still has his thyroid. He takes no thyroid medication. And the physician who performed his follow-up biopsy in Indianapolis, hearing the history for the first time, asked for more information about the procedure. He had no idea ablation was being used on thyroids, and he wanted to learn.

What Patients Should Take From This

Barker’s advice to anyone facing a thyroid cancer diagnosis comes down to advocacy. “Make sure you are your own advocate,” he said. “You’ve got to search out alternative procedures and then do your research.”

Three points from his story deserve emphasis for anyone told they need a thyroidectomy.

First, a papillary thyroid cancer diagnosis is rarely an emergency. The nodule may have been present for years. Patients have time to get informed, seek second opinions, and understand every option before consenting to the permanent removal of an organ.

Second, the absence of an option at your hospital does not mean the option does not exist. Barker’s network never mentioned ablation because it had no one trained to perform it. Patients who stop at their local system’s menu of treatments may never learn what is available elsewhere.

Third, expertise is not interchangeable. Thyroid ablation for cancer is performed by a small group of specialists with deep case experience. Choosing the right physician is as important as choosing the right procedure.

Insurance coverage for thyroid ablation varies, and many patients, including Barker, pay out of pocket. He does not consider it a close call. “It is so worth doing it to maintain your quality of life,” he said. “I would definitely recommend it to anybody.”

He puts the alternative simply. “I could be sitting here today without a thyroid, taking a pill, and who knows what side effects from it.”